Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Moulder

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Iscience|January 15, 2019
Quantitative Proteomics Reveals the Dynamic Protein Landscape during Initiation of Human Th17 Cell PolarizationSubhash K Tripathi, Tommi Välikangas, Ankitha Shetty, et al.
Scientific Reports|September 24, 2023
Serum APOC1 levels are decreased in young autoantibody positive children who rapidly progress to type 1 diabetesM Karoliina Hirvonen, Niina Lietzén, Robert Moulder, et al.
Scientific Reports|June 17, 2018
Serum Proteomic Profiling to Identify Biomarkers of Premature Carotid AtherosclerosisSantosh D Bhosale, Robert Moulder, Mikko S Venäläinen, et al.
Diabetes|January 25, 2015
Serum proteomes distinguish children developing type 1 diabetes in a cohort with HLA-conferred susceptibilityRobert Moulder, Santosh D Bhosale, Timo Erkkilä, et al.
Diabetologia|August 3, 2023
Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes distinguishes markers of disease and C-peptide trajectoryRobert Moulder, Tommi Välikangas, M Karoliina Hirvonen, et al.
BMC Medicine|April 24, 2026
Therapeutic TG2 inhibition reverses systemic multiomic dysregulation in celiac diseaseValeriia Dotsenko, Hana Hien Le, Sonja Rajić, et al.
Diabetes/Metabolism Research and Reviews|July 4, 2024
Multi-omics analysis reveals drivers of loss of β-cell function after newly diagnosed autoimmune type 1 diabetes: An INNODIA multicenter studyJose Juan Almagro Armenteros, Caroline Brorsson, Christian Holm Johansen, et al.
Journal of Psychosomatic Research|August 31, 2020
Time to get personal? The impact of researchers choices on the selection of treatment targets using the experience sampling methodologyJojanneke A Bastiaansen, Yoram K Kunkels, Frank J Blaauw, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Iscience|January 15, 2019
Quantitative Proteomics Reveals the Dynamic Protein Landscape during Initiation of Human Th17 Cell PolarizationSubhash K Tripathi, Tommi Välikangas, Ankitha Shetty, et al.
Scientific Reports|September 24, 2023
Serum APOC1 levels are decreased in young autoantibody positive children who rapidly progress to type 1 diabetesM Karoliina Hirvonen, Niina Lietzén, Robert Moulder, et al.
Scientific Reports|June 17, 2018
Serum Proteomic Profiling to Identify Biomarkers of Premature Carotid AtherosclerosisSantosh D Bhosale, Robert Moulder, Mikko S Venäläinen, et al.
Diabetes|January 25, 2015
Serum proteomes distinguish children developing type 1 diabetes in a cohort with HLA-conferred susceptibilityRobert Moulder, Santosh D Bhosale, Timo Erkkilä, et al.
Diabetologia|August 3, 2023
Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes distinguishes markers of disease and C-peptide trajectoryRobert Moulder, Tommi Välikangas, M Karoliina Hirvonen, et al.
BMC Medicine|April 24, 2026
Therapeutic TG2 inhibition reverses systemic multiomic dysregulation in celiac diseaseValeriia Dotsenko, Hana Hien Le, Sonja Rajić, et al.
Diabetes/Metabolism Research and Reviews|July 4, 2024
Multi-omics analysis reveals drivers of loss of β-cell function after newly diagnosed autoimmune type 1 diabetes: An INNODIA multicenter studyJose Juan Almagro Armenteros, Caroline Brorsson, Christian Holm Johansen, et al.
Journal of Psychosomatic Research|August 31, 2020
Time to get personal? The impact of researchers choices on the selection of treatment targets using the experience sampling methodologyJojanneke A Bastiaansen, Yoram K Kunkels, Frank J Blaauw, et al.
Pageof 5